Table 2.
Characteristics of patients with liver abscess formation after DEB-TACE (n = 12)
| Age (year) | Gender | Comorbidities | SC before procedure | Child-Pugh classification | ECOG Score | Leukocyte count* | Primary tumors | Tumor number | MTD (cm) | PVTT | Degree of artery occlusion | Selectivity of embolization | Prophylactic antibiotics | Blood bacterial culture | Pus bacterial culture |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45 | M | N/A | N/A | A | 0 | 5.6 | CRC | 2 | 6.4 | No | 1 | Sub segmental | No | – | E.coli |
| 58 | M | N/A | >=3 m | A | 0 | 4.9 | GC | 2 | 3.8 | No | 1 | Sub- segmental | No | – | N/A |
| 47 | F | BA | >=3 m | A | 0 | 5.3 | GC | >=3 | 5.4 | No | 1 | Sub- segmental | No | E.coli | E.coli |
| 73 | M | CLD | <3 m | A | 0 | 6.7 | PC | 1 | 7.1 | No | 1 | Segmental | No | Citrobacter freundii | Citrobacter freundii |
| 54 | F | DM | <3 m | A | 0 | 5.1 | CRC | >=3 | 5.7 | Yes | 1 | Sub- segmental | No | E.coli | E.coli |
| 39 | M | N/A | <3 m | A | 1 | 9.2 | CRC | >=3 | 9.2 | No | 0 | Segmental | Yes | – | E.coli |
| 71 | M | N/A | >=3 m | A | 0 | 7.4 | NPC | >=3 | 5.9 | No | 1 | Lobar | No | – | E.coli |
| 55 | F | N/A | >=3 m | A | 0 | 6.3 | LC | >=3 | 6.9 | Yes | 1 | Sub- segmental | No | Klebsiella pneumonia | Klebsiella pneumonia |
| 62 | M | CLD | >=3 m | A | 1 | 5.9 | LC | >=3 | 8.1 | No | 1 | Segmental | No | E.coli | E.coli |
| 49 | F | N/A | >=3 m | B | 0 | 5.5 | CRC | 2 | 5.3 | No | 1 | Sub- segmental | No | – | Enterobacter cloacaeand |
| 68 | M | DM +CLD | <3 m | A | 0 | 6.2 | GC | >=3 | 7.2 | No | 1 | Sub- segmental | No | – | Klebsiella pneumonia |
| 52 | F | N/A | <3 m | A | 0 | 6.8 | CRC | 2 | 8.7 | No | 0 | Sub- segmental | No | – | Citrobacter freundii |
BA, bilioenteric anastomosis; CLD, chronic liver disease; DM, diabetes mellitus; E. coli, Escherichia coli; MTD, maximum tumor diameter; PVTT, portal vein tumor thrombosis; SC, systemic chemotherapy.
Notes: *×109 l−1.